CD39/vascular ATP diphosphohydrolase modulates xenograft survival.
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.
M
M
Imai
K
K
Takigami
O
O
Guckelberger
Y
Y
Lin
J
J
Sevigny
E
E
Kaczmarek
C
C
Goepfert
K
K
Enjyoji
F H
FH
Bach
R D
RD
Rosenberg
S C
SC
Robson
D000251:Adenosine Triphosphatases; D000818:Animals; D000920:Antibody-Dependent Cell Cytotoxicity; D015703:Antigens, CD / Q000502:physiology*; D001081:Apyrase / Q000378:metabolism*; D003331:Coronary Vessels / Q000201:enzymology*; D006085:Graft Survival / Q000502:physiology*; D006168:Guinea Pigs; D016027:Heart Transplantation / Q000276:immunology / Q000502:physiology*; D051379:Mice; D008810:Mice, Inbred C57BL; D008815:Mice, Inbred Strains; D018345:Mice, Knockout; D051381:Rats; D011917:Rats, Inbred Lew; D014183:Transplantation, Heterologous / Q000276:immunology / Q000502:physiology*
D015703:Antigens, CD; D000251:Adenosine Triphosphatases; D001081:Apyrase; C067869:CD39 antigen